Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder

  • Michio Hirano
  • , Gabriella Silvestri
  • , D. M. Blake
  • , A. Lombes
  • , C. Minetti
  • , E. Bonilla
  • , A. P. Hays
  • , R. E. Lovelace
  • , I. Butler
  • , T. E. Bertorini
  • , A. B. Threlkeld
  • , H. Mitsumoto
  • , L. M. Salberg
  • , L. P. Rowland
  • , S. Dimauro
  • Columbia University
  • Lexington Clinic
  • University of Texas Health Science Center at Houston
  • University of Tennessee Health Science Center
  • Johns Hopkins University
  • Cleveland Clinic Foundation
  • Indiana University Bloomington

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

We studied the clinical, biochemical, and genetic features of eight patients with the autosomal recessive mitochondrial syndrome mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). MNGIE is clinically characterized by ophthalmoparesis, peripheral neuropathy, leukoencephalopathy, gastrointestinal symptoms (recurrent nausea, vomiting, or diarrhea) with intestinal dysmotility, and histologically abnormal mitochondria in muscle. Brain MRI scans were consistent with leukodystrophy in seven patients examined. Nerve conduction and EMG studies were compatible with a sensorimotor neuropathy; quantitative EMG of two patients suggested a myogenic process. Muscle mitochondrial enzyme analysis revealed a partial defect of cytochrome c oxidase activity in five patients; three had additional respiratory chain enzyme defects. Two patients had isolated complex I defects, and one had normal respiratory chain function. Southern blot analysis revealed multiple deletions of mitochondrial DNA in four of eight patients. © 1994 American Academy of Neurology.
Lingua originaleInglese
pagine (da-a)721-727
Numero di pagine7
RivistaNeurology
Volume44
DOI
Stato di pubblicazionePubblicato - 1994

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Keywords

  • MNGIE
  • mitochondrial myopathy
  • mtDNA

Fingerprint

Entra nei temi di ricerca di 'Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder'. Insieme formano una fingerprint unica.

Cita questo